Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. We conducted a multi-stage genome-wide association study for PrCa and previously reported the results of the first two stages, which identified 16 PrCa susceptibility loci. We report here the results of stage 3, in which we evaluated 1,536 SNPs in 4,574 individuals with prostate cancer (cases) and 4,164 controls. We followed up ten new association signals through genotyping in 51,311 samples in 30 studies from the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) consortium. In addition to replicating previously reported loci, we identified seven new prostate cancer susceptibility loci on chromosomes 2p11, 3q23, 3q26, 5p12, 6p21, 12q13 and Xq12 (P = 4.0 × 10-8 to P = 2.7 × 10-24). We also identified a SNP in TERT more strongly associated with PrCa than that previously reported. More than 40 PrCa susceptibility loci, explaining 425% of the familial risk in this disease, have now been identified.

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.

CAMPA, DANIELE;
2011

Abstract

Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. We conducted a multi-stage genome-wide association study for PrCa and previously reported the results of the first two stages, which identified 16 PrCa susceptibility loci. We report here the results of stage 3, in which we evaluated 1,536 SNPs in 4,574 individuals with prostate cancer (cases) and 4,164 controls. We followed up ten new association signals through genotyping in 51,311 samples in 30 studies from the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) consortium. In addition to replicating previously reported loci, we identified seven new prostate cancer susceptibility loci on chromosomes 2p11, 3q23, 3q26, 5p12, 6p21, 12q13 and Xq12 (P = 4.0 × 10-8 to P = 2.7 × 10-24). We also identified a SNP in TERT more strongly associated with PrCa than that previously reported. More than 40 PrCa susceptibility loci, explaining 425% of the familial risk in this disease, have now been identified.
Kote Jarai, Z; Olama, Aa; Giles, Gg; Severi, G; Schleutker, J; Weischer, M; Campa, Daniele; Riboli, E; Key, T; Gronberg, H; Hunter, Dj; Kraft, P; Thun, Mj; Ingles, S; Chanock, S; Albanes, D; Hayes, Rb; Neal, De; Hamdy, Fc; Donovan, Jl; Pharoah, P; Schumacher, F; Henderson, Be; Stanford, Jl; Ostrander, Ea; Sorensen, Kd; Dörk, T; Andriole, G; Dickinson, Jl; Cybulski, C; Lubinski, J; Spurdle, A; Clements, Ja; Chambers, S; Aitken, J; Gardiner, Ra; Thibodeau, Sn; Schaid, D; John, Em; Maier, C; Vogel, W; Cooney, Ka; Park, Jy; Cannon Albright, L; Brenner, H; Habuchi, T; Zhang, Hw; Lu, Yj; Kaneva, R; Muir, K; Benlloch, S; Leongamornlert, Da; Saunders, Ej; Tymrakiewicz, M; Mahmud, N; Guy, M; O'Brien, Lt; Wilkinson, Ra; Hall, Al; Sawyer, Ej; Dadaev, T; Morrison, J; Dearnaley, Dp; Horwich, A; Huddart, Ra; Khoo, Vs; Parker, Cc; Van As, N; Woodhouse, Cj; Thompson, A; Christmas, T; Ogden, C; Cooper, Cs; Lophatonanon, A; Southey, Mc; Hopper, Jl; English, Dr; Wahlfors, T; Tammela, Tl; Klarskov, P; Nordestgaard, Bg; Røder, Ma; Tybjærg Hansen, A; Bojesen, Se; Travis, R; Canzian, F; Kaaks, R; Wiklund, F; Aly, M; Lindstrom, S; Diver, Wr; Gapstur, S; Stern, Mc; Corral, R; Virtamo, J; Cox, A; Haiman, Ca; Le Marchand, L; Fitzgerald, L; Kolb, S; Kwon, Em; Karyadi, Dm; Orntoft, Tf; Borre, M; Meyer, A; Serth, J; Yeager, M; Berndt, Si; Marthick, Jr; Patterson, B; Wokolorczyk, D; Batra, J; Lose, F; Mcdonnell, Sk; Joshi, Ad; Shahabi, A; Rinckleb, Ae; Ray, A; Sellers, Ta; Lin, Hy; Stephenson, Ra; Farnham, J; Muller, H; Rothenbacher, D; Tsuchiya, N; Narita, S; Cao, Gw; Slavov, C; Mitev, V; Easton, Df; Eeles, Ra; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of, Oncology; UK ProtecT Study, Collaborators; The Australian Prostate Cancer, Bioresource; Practical, Consortium
File in questo prodotto:
File Dimensione Formato  
Kote_Jarai_NG_2011.pdf

solo utenti autorizzati

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 635.29 kB
Formato Adobe PDF
635.29 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11568/460271
Citazioni
  • ???jsp.display-item.citation.pmc??? 162
  • Scopus 239
  • ???jsp.display-item.citation.isi??? 222
social impact